defer us trials until cashflow, page-23

With all due respect bums, that wasnt the reason. The reason is that at the moment, the company lacks market credibility for repeatedly failing to meet targets as is refelected in the SP. A CR ahead of the CE mark and sales would have to be at a substantial discount to the current SP (think mid teens), which will not only decimate the SP, but will lead to a massive dilution of all current holders. The losses that I and other holders have endured makes it unlikely that there would be any significant take-up in a rights issue, which means it would have to be underwritten, which in turn entails the CR would be at bargain basement prices. It might help all the holders who have bailed out in the last few weeks of course, but not those who have elected to continue to hold.